Molecules 2001, 6(3), 142-193; doi:10.3390/60300142
Review

Muscarinic Receptor Agonists and Antagonists

Kenneth J. Broadley 1  and David R. Kelly 2,* email
1 Division of Pharmacology, Welsh School of Pharmacy, Cardiff University, Cathays Park, Cardiff, CF10 3TB, UK 2 Department of Chemistry, Cardiff University, Cathays Park, Cardiff, CF10 3TB, UK
* Author to whom correspondence should be addressed.
Received: 2 May 2000; in revised form: 16 January 2001 / Accepted: 16 January 2001 / Published: 28 February 2001
PDF Full-text Download PDF Full-Text [320 KB, uploaded 3 October 2008 14:21 CEST]
Abstract: A comprehensive review of pharmacological and medical aspects of the muscarinic class of acetylcholine agonists and antagonists is presented. The therapeutic benefits of achieving receptor subtype selectivity are outlined and applications in the treatment of Alzheimer’s disease are discussed. A selection of chemical routes are described, which illustrate contemporary methodology for the synthesis of chiral medicinal compounds (asymmetric synthesis, chiral pool, enzymes). Routes to bicyclic intrannular amines and intramolecular Diels-Alder reactions are highlighted.
Keywords: Alzheimer’s disease; nicotine; acetylcholine; arecoline; himbacine; tacrine; cyclostelletamines; intramolecular Diels-Alder reaction; indole alkaloids

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Broadley, K.J.; Kelly, D.R. Muscarinic Receptor Agonists and Antagonists. Molecules 2001, 6, 142-193.

AMA Style

Broadley KJ, Kelly DR. Muscarinic Receptor Agonists and Antagonists. Molecules. 2001; 6(3):142-193.

Chicago/Turabian Style

Broadley, Kenneth J.; Kelly, David R. 2001. "Muscarinic Receptor Agonists and Antagonists." Molecules 6, no. 3: 142-193.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert